title: Cancer treatment and survivorship statistics, 2016.
abstract: The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results cancer registries. In addition, current treatment patterns for the most prevalent cancer types are presented based on information in the National Cancer Data Base and treatment-related side effects are briefly described. More than 15.5 million Americans with a history of cancer were alive on January 1, 2016, and this number is projected to reach more than 20 million by January 1, 2026. The 3 most prevalent cancers are prostate (3,306,760), colon and rectum (724,690), and melanoma (614,460) among males and breast (3,560,570), uterine corpus (757,190), and colon and rectum (727,350) among females. More than one-half (56%) of survivors were diagnosed within the past 10 years, and almost one-half (47%) are aged 70 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by primary care providers. Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care. CA Cancer J Clin 2016;66:271-289. © 2016 American Cancer Society.
authors.affiliation: Epidemiologist, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.
authors.forename: Kimberly D
authors.initials: KD
authors.lastname: Miller
authors.affiliation: Strategic Director, Surveillance Information, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.
authors.forename: Rebecca L
authors.initials: RL
authors.lastname: Siegel
authors.affiliation: Director, Health Services Research, Intramural Research Department, American Cancer Society, Atlanta, GA.
authors.forename: Chun Chieh
authors.initials: CC
authors.lastname: Lin
authors.affiliation: Branch Chief, Surveillance Research Program, National Cancer Institute, Bethesda, MD.
authors.forename: Angela B
authors.initials: AB
authors.lastname: Mariotto
authors.affiliation: Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA.
authors.forename: Joan L
authors.initials: JL
authors.lastname: Kramer
authors.affiliation: Director, Office of Cancer Survivorship, National Cancer Institute, Bethesda, MD.
authors.forename: Julia H
authors.initials: JH
authors.lastname: Rowland
authors.affiliation: Vice President, Behavioral Research Center, American Cancer Society, Atlanta, GA.
authors.forename: Kevin D
authors.initials: KD
authors.lastname: Stein
authors.affiliation: Medical Editor, American Cancer Society, Atlanta, GA.
authors.forename: Rick
authors.initials: R
authors.lastname: Alteri
authors.affiliation: Vice President, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.
authors.forename: Ahmedin
authors.initials: A
authors.lastname: Jemal
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000570:American Cancer Society; D001943:Breast Neoplasms / Q000401:mortality / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003110:Colonic Neoplasms / Q000401:mortality / Q000628:therapy; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008545:Melanoma / Q000401:mortality / Q000628:therapy; D008875:Middle Aged; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000401:mortality* / Q000628:therapy*; D015995:Prevalence; D011471:Prostatic Neoplasms / Q000401:mortality / Q000628:therapy; D012042:Registries; D012307:Risk Factors; D012878:Skin Neoplasms / Q000401:mortality / Q000628:therapy; D015996:Survival Rate; D017741:Survivors / Q000706:statistics & numerical data*; D014481:United States / Q000453:epidemiology; D014594:Uterine Neoplasms / Q000401:mortality / Q000628:therapy
keywords: prevalence; statistics; survivorship; treatment patterns